SysmexSSMXF +5.89%74 Net Margin % is 1.27% as of Mar. 2026, which is 89% below its 10-year median of 11.35. GuruFocus rates SSMXF with a GF Score™ of 74/100 and a GF Value™ of $17.55 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 818 Medical Devices & Instruments companies, Sysmex ranks better than 65.4% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Sysmex's Net Income for the
three
months ended in Mar. 2026 was $11 Mil. Sysmex's Revenue for the
three
months ended in Mar. 2026 was $875 Mil. Therefore, Sysmex's net margin for the quarter that ended in Mar. 2026 was 1.27%.
The historical rank and industry rank for Sysmex's Net Margin % or its related term are showing as below:
SSMXF'
s Net Margin % Range Over the Past 10 Years
Min: 7.09 Med: 11.35 Max: 16.26
Current: 7.09
SSMXF's Net Margin % is ranked better than 65.4% of 818
companies
in the Medical Devices & Instruments industry
Industry Median: 2.06
vs SSMXF: 7.09
Sysmex (OTCPK:SSMXF) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Sysmex Net Margin % Related Terms
Sysmex Net Margin % Historical Data
* Premium members only.
The historical data trend for Sysmex's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Sysmex's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sysmex Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sysmex's Net Margin % distribution charts can be found below:
* The bar in red indicates where Sysmex's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sysmex (SSMXF) has a Net Margin % of 1.27% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Sysmex and its competitors. This is 89% below median its historical median of 11.35. Over the past decade, Sysmex's Net Margin % has ranged from 7.09 to 16.26. According to the industry distribution chart, Sysmex ranks #283 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 34.6%.
Is Sysmex's Net Margin % too high?
Sysmex's current Net Margin % of 1.27% is 89% below median its 10-year median of 11.35. Over the past 10 years, this metric has ranged from a low of 7.09 to a high of 16.26. The Medical Devices & Instruments industry median Net Margin % is 2.06. Sysmex's value of 1.27% is 38.3% below this industry median. Based on the distribution chart, Sysmex ranks #283 out of 818 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sysmex has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sysmex's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sysmex ranks #283 out of 818 companies for Net Margin %. This puts Sysmex in the upper half of its industry. The industry median Net Margin % is 2.06. Sysmex's value of 1.27% is 38.3% below this benchmark. Historically, Sysmex's own Net Margin % has ranged from 7.09 to 16.26 over the past decade. While the company's 10-year median is 11.35 vs. the industry median of 2.06, Sysmex has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.06, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sysmex's current Net Margin % of 1.27% is 38.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Sysmex and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sysmex's current Net Margin % is 1.27%, which is 89% below median its own 10-year median of 11.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sysmex stock overvalued right now?
Based on GuruFocus' analysis, Sysmex (SSMXF) is currently considered Significantly Undervalued. The stock's GF Value™ is $17.55, compared to a current price of $8.85 — trading 49.6% below its estimated fair value. The current Net Margin % is 1.27%, which is 89% below median its 10-year median of 11.35 and 38.3% below the Medical Devices & Instruments industry median of 2.06. Sysmex's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Sysmex (SSMXF), the current Net Margin % is 1.27% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sysmex (SSMXF) Overvalued in 2026?
Based on GuruFocus' analysis, Sysmex stock appears to be undervalued.
The current stock price of $8.85 is trading 49.6% below its estimated GF Value™ of $17.55.
GuruFocus considers Sysmex to be Significantly Undervalued.
Key valuation signals for SSMXF:
Net Margin %: 1.27% (89% below median its 10-year median of 11.35)
GF Value™: $17.55 vs. price of $8.85 (49.6% below fair value)
Industry Position: 38.3% below the Medical Devices & Instruments median (#283 of 818)
No single metric tells the full story. See the SSMXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sysmex Corp manufactures and sells laboratory testing equipment and reagents. It conducts product development, manufacturing, sales, and service activities in domestic markets, while certain products are also developed, manufactured, and sold through its subsidiaries. The company operates through five reportable segments based on headquarters: Head Office Management, Americas Headquarters, EMEA Headquarters, China Headquarters, and AP Headquarters.
74GF Score
Get the complete analysis for SSMXF
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SSMXF has been successfully added to your 
